RESUMEN
Angiogenic sprouting can contribute adaptively, or mal-adaptively, to a myriad of conditions including ischemic heart disease and cancer. While the cellular and molecular systems that regulate tip versus stalk endothelial cell (EC) specification during angiogenesis are known, those systems that regulate their distinct actions remain poorly understood. Pre-clinical and clinical findings support sustained adrenergic signaling in promoting angiogenesis, but links between adrenergic signaling and angiogenesis are lacking; importantly, adrenergic agents alter the activation status of the cAMP signaling system. Here, we show that the cAMP effector, PKA, acts in a cell autonomous fashion to constitutively reduce the in vitro and ex vivo angiogenic sprouting capacity of ECs. At a cellular level, we observed that silencing or inhibiting PKA in human ECs increased their invasive capacity, their generation of podosome rosettes and, consequently, their ability to degrade a collagen matrix. While inhibition of either Src-family kinases or of cdc42 reduced these events in control ECs, only cdc42 inhibition, or silencing, significantly impacted them in PKA(Cα)-silenced ECs. Consistent with these findings, cell-based measurements of cdc42 activity revealed that PKA activation inhibits EC cdc42 activity, at least in part, by promoting its interaction with the inhibitory regulator, guanine nucleotide dissociation inhibitor-α (RhoGDIα).
Asunto(s)
Proteínas Quinasas Dependientes de AMP Cíclico/fisiología , Células Endoteliales/metabolismo , Neovascularización Patológica , Neovascularización Fisiológica/efectos de los fármacos , Podosomas , Proteína de Unión al GTP cdc42/fisiología , Línea Celular , Proteínas Quinasas Dependientes de AMP Cíclico/antagonistas & inhibidores , Células Endoteliales/citología , Células Endoteliales/patología , Humanos , Neovascularización Fisiológica/fisiología , Podosomas/efectos de los fármacos , Proteína de Unión al GTP cdc42/antagonistas & inhibidores , Inhibidor alfa de Disociación del Nucleótido Guanina rho/farmacología , Familia-src Quinasas/antagonistas & inhibidores , Familia-src Quinasas/fisiologíaRESUMEN
BACKGROUND: Proteases play a major role in inflammatory diseases of the gastrointestinal tract. Activatable probes are a major technological advance, enabling sensitive detection of active proteases in tissue samples. Our aim was to synthesize an activatable probe for cathepsin S and validate its use in a mouse model of colitis. METHODS: We designed and synthesized a new fluorescent activatable probe, NB200, for the detection of active cathepsin S. Colitis was induced in C57BL/6 mice by the administration of 3% dextran sulfate sodium (DSS). Homogenized mouse colons, with or without the addition of the specific cathepsin S inhibitor MV026031, were incubated with NB200 in a fluorescent plate reader. KEY RESULTS: NB200 selectively detected purified cathepsin S and not other common inflammatory proteases. Homogenates of colon from mice with DSS colitis induced a significant fluorescent increase when compared to control animals (control vs DSS: p < 0.05 at 200 min and p < 0.01 at 220-240 min), indicating cathepsin S activation. The cathepsin S inhibitor abolished this increase in fluorescence (DSS vs DSS + MV026031: p < 0.05 at 140 min, p < 0.01 at 180 min, p < 0.001 at 200-240 min), which confirms cathepsin S activation. Cathepsin S activity correlated with the disease activity index (Spearman r = 0.77, p = 0.017). CONCLUSIONS & INFERENCES: Our investigation has demonstrated the utility of activatable probes for detecting protease activity in intestinal inflammation. Panels of such probes may allow 'signature' protease profiles to be established for a range of inflammatory diseases and disorders.
Asunto(s)
Catepsinas/análisis , Colitis/enzimología , Colorantes Fluorescentes/síntesis química , Colorantes Fluorescentes/farmacología , Animales , Colitis/inducido químicamente , Sulfato de Dextran/toxicidad , Modelos Animales de Enfermedad , Ratones , Ratones Endogámicos C57BLRESUMEN
Aberrant epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer (NSCLC) is linked to tumor progression, metastasis and poor survival rates. Here we report the role of Cdc42-interacting protein 4 (CIP4) in the regulation of NSCLC cell invasiveness and tumor metastasis. CIP4 was highly expressed in a panel of NSCLC cell lines and normal lung epithelial cell lines. Stable knockdown (KD) of CIP4 in lung adenocarcinoma H1299 cells, expressing wild-type EGFR, led to increased EGFR levels on the cell surface and defects in sustained activation of Erk kinase in H1299 cells treated with EGF. CIP4 localized to leading edge projections in NSCLC cells, and CIP4 KD cells displayed defects in EGF-induced cell motility and invasion through extracellular matrix. This correlated with reduced expression and activity of matrix metalloproteinase-2 (MMP-2) in CIP4 KD cells compared with control. In xenograft assays, CIP4 silencing had no effect on tumor growth but resulted in significant defects in spontaneous metastases to the lungs from these subcutaneous tumors. This correlated with reduced expression of the Erk target gene Zeb1 and the Zeb1 target gene MMP-2 in CIP4 KD tumors compared with control. CIP4 also enhanced rates of metastasis to the liver and lungs in an intrasplenic experimental metastasis model. In human NSCLC tumor sections, CIP4 expression was elevated greater than or equal to twofold in 43% of adenocarcinomas and 32% of squamous carcinomas compared with adjacent normal lung tissues. Analysis of microarray data for NSCLC patients also revealed that high CIP4 transcript levels correlated with reduced overall survival. Together, these results identify CIP4 as a positive regulator of NSCLC metastasis and a potential poor prognostic biomarker in lung adenocarcinoma.
Asunto(s)
Adenocarcinoma/diagnóstico , Adenocarcinoma/patología , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/patología , Proteínas Asociadas a Microtúbulos/fisiología , Adenocarcinoma/genética , Adenocarcinoma/mortalidad , Adenocarcinoma del Pulmón , Anciano , Animales , Biomarcadores de Tumor/fisiología , Carcinoma de Pulmón de Células no Pequeñas/diagnóstico , Carcinoma de Pulmón de Células no Pequeñas/genética , Carcinoma de Pulmón de Células no Pequeñas/mortalidad , Carcinoma de Pulmón de Células no Pequeñas/patología , Células Cultivadas , Humanos , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/mortalidad , Masculino , Ratones , Ratones Noqueados , Persona de Mediana Edad , Antígenos de Histocompatibilidad Menor , Metástasis de la Neoplasia , Pronóstico , Análisis de SupervivenciaRESUMEN
Metastatic breast adenocarcinomas display activation signatures for signaling pathways that trigger cell motility and tissue invasion. Here, we report that the adaptor protein transducer of Cdc42-dependent actin assembly-1 (Toca-1) is expressed in highly invasive breast cancers and regulates their metastatic phenotypes. We show that Toca-1 localizes to the filamentous actin-rich core of invadopodial protrusions actively degrading the extracellular matrix (ECM). Toca-1 colocalizes with Cortactin, and we show that this interaction is mediated by the SH3 domain of Toca-1. Stable knockdown (KD) of Toca-1 expression in MDA-MB-231 cells led to a significant defect in epidermal growth factor (EGF)-induced cell migration and invasion. Toca-1 KD cells also showed significant defects in EGF- and Src-induced ECM digestion and formation of invadopodial membrane protrusions. To test the role of Toca-1 in metastasis, we achieved stable Toca-1 KD in both human and rat metastatic breast adenocarcinoma cell lines. Orthotopic tumor xenografting of control and Toca-1 KD cells in natural-killer /B-/T-cell-deficient mice revealed a significant defect in spontaneous lung metastases with Toca-1 silencing in vivo. In contrast, no defects in primary tumor growth or lung seeding following tail vein injection of Toca-1 KD cells was observed, suggesting that Toca-1 functions at an early step in the dissemination of metastatic breast tumor cells. Taken together, our results identify Toca-1 as a proinvasive protein in breast adenocarcinoma and a potential therapeutic target to limit tumor metastasis.
Asunto(s)
Adenocarcinoma/patología , Neoplasias de la Mama/patología , Proteínas Portadoras/metabolismo , Matriz Extracelular/metabolismo , Adenocarcinoma/metabolismo , Animales , Neoplasias de la Mama/metabolismo , Proteínas Portadoras/genética , Línea Celular Tumoral , Movimiento Celular , Extensiones de la Superficie Celular/metabolismo , Cortactina , Factor de Crecimiento Epidérmico/metabolismo , Femenino , Humanos , Ratones , Invasividad Neoplásica , Metástasis de la Neoplasia , RatasRESUMEN
BACKGROUND: Imidocarb or a combination of atovaquone and azithromycin (A&A) has been suggested for treatment of cats with cytauxzoonosis, but neither has been prospectively evaluated for efficacy. HYPOTHESIS/OBJECTIVES: That survival to hospital discharge is improved by treatment with A&A as compared with imidocarb. ANIMALS: Eighty acutely ill cats with Cytauxzoon felis infection treated at one of 18 veterinary clinics in 5 states. METHODS: An open-label, randomized prospective study compared survival in cats treated with atovaquone (15 mg/kg p.o. q8h) and azithromycin (10 mg/kg p.o. q24h) or imidocarb (3.5 mg/kg i.m.). All received heparin, fluids, and supportive care. Clinical and clinicopathologic data from initial presentation were collated. Parasitemia was quantified (n = 79) and pathogens genotyped (n = 60). Logistic regression was used to determine the impact of treatment group on the primary endpoint, survival to hospital discharge or death. Covariants were analyzed by rank-sum testing. RESULTS: Of 53 cats treated with A&A, 32 (60%) survived to discharge while only 7 of 27 cats (26%) treated with imidocarb survived (P = .0036; odds ratio 7.2, 95% CI 2.2, 24). Cats with a lower parasitemia were more likely to survive, as were cats with higher white blood cell counts and lower total bilirubin. Unique pathogen genotypes were identified from 15 cats, while genotype isolated from 21 cats had been described previously. There were multiple pathogen genotypes identified in 24 cats. CONCLUSIONS AND CLINICAL IMPORTANCE: Survival to discharge was more likely in cats treated with A&A as compared with imidocarb, although case fatality rate remained high.
Asunto(s)
Antiprotozoarios/uso terapéutico , Atovacuona/uso terapéutico , Azitromicina/uso terapéutico , Enfermedades de los Gatos/tratamiento farmacológico , Imidocarbo/análogos & derivados , Piroplasmida/aislamiento & purificación , Infecciones Protozoarias en Animales/tratamiento farmacológico , Animales , Enfermedades de los Gatos/parasitología , Gatos , ADN Protozoario/química , ADN Protozoario/genética , Quimioterapia Combinada/veterinaria , Femenino , Genotipo , Imidocarbo/uso terapéutico , Modelos Logísticos , Masculino , Parasitemia/tratamiento farmacológico , Parasitemia/parasitología , Parasitemia/veterinaria , Piroplasmida/genética , Reacción en Cadena de la Polimerasa/veterinaria , Estudios Prospectivos , Infecciones Protozoarias en Animales/parasitología , Análisis de SupervivenciaRESUMEN
BACKGROUND AND AIMS: Fer kinase is activated by a number of growth factors and cytokines, and phosphorylates cortactin during cell shape change induced cortical actin reorganisation. In addition, Fer participates in cytoskeletal interactions mediated by cadherins, platelet endothelial cell adhesion molecule 1 (PECAM-1), and integrins, and has recently been implicated in limiting the innate immune response. Here we examined the role of Fer in modulating leucocyte recruitment and epithelial barrier function in the gut in response to lipopolysaccharide (LPS). METHODS: Mice targeted with a kinase inactivating mutation (FerDR) or strain matched wild-type (129Sv/J) mice were studied after intraperitoneal injection of LPS. Intravital microscopy was used to examine intestinal leucocyte kinetics, and leucocyte infiltration was assessed by fluorescence activated cell sorting. Systemic inflammation was assessed by measuring lung myeloperoxidase activity. Epithelial barrier function was assessed in vivo using blood to lumen 51Cr-EDTA clearance, with or without antibody based depletion of circulating neutrophils. RESULTS: LPS induced a significant increase in leucocyte adhesion and neutrophil infiltration into the intestinal tissue, and increased blood to lumen 51Cr-EDTA clearance. Pretreatment with neutrophil depleting antibody completely abrogated this response in wild-type mice. In FerDR mice, LPS induced leucocyte adhesion within the intestinal venules was exacerbated and associated with a trend towards increased neutrophil transmigration relative to wild-type mice. Surprisingly, LPS induced epithelial barrier permeability was increased 2.5-fold in FerDR mice relative to wild-type mice, and this barrier defect was only partly attenuated by depleting circulating neutrophils by >93 %. CONCLUSIONS: Fer plays a role in regulating LPS induced epithelial barrier dysfunction in vivo through both neutrophil dependent and neutrophil independent mechanisms.
Asunto(s)
Células Epiteliales/inmunología , Intestinos/inmunología , Leucocitos/inmunología , Proteínas Proto-Oncogénicas/fisiología , Animales , Adhesión Celular/inmunología , Movimiento Celular/inmunología , Inmunidad Celular , Intestino Delgado/inmunología , Recuento de Leucocitos/métodos , Lipopolisacáridos/inmunología , Ratones , Neutrófilos/inmunología , Permeabilidad , Proteínas Tirosina Quinasas/inmunología , Proteínas Proto-Oncogénicas/inmunologíaRESUMEN
Fps/Fes and Fer proto-oncoproteins are structurally related non-receptor protein-tyrosine kinases implicated in signaling downstream from cytokines, growth factors and immune receptors. We show that Fps/Fes and Fer are expressed in human and mouse platelets, and are activated following stimulation with collagen and collagen-related peptide (CRP), suggesting a role in GPVI receptor signaling. Fer was also activated following stimulation with thrombin and a protease-activated receptor4 (PAR4)-activating peptide, suggesting a role in signaling downstream from the G protein-coupled PAR4. There were no detectable perturbations in CRP-induced activation of Syk, PLCgamma2, cortactin, Erk, Jnk, Akt or p38 in platelets from mice lacking Fps/Fes, Fer, or both kinases. Platelets lacking Fps/Fes, from a targeted fps/fes null strain of mice, showed increased rates and amplitudes of collagen-induced aggregation, relative to wild-type platelets. P-Selectin expression was also elevated on the surface of Fps/Fes-null platelets in response to CRP. Fer-deficient platelets, from mice targeted with a kinase-inactivating mutation, disaggregated more rapidly than wild-type platelets in response to ADP. This report provides the first evidence that Fps/Fes and Fer are expressed in platelets and become activated downstream from the GPVI collagen receptor, and that Fer is activated downstream from a G-protein coupled receptor. Furthermore, using targeted mouse models we show that deficiency in Fps/Fes or Fer resulted in disregulated platelet aggregation and disaggregation, demonstrating a role for these kinases in regulating platelet functions.
Asunto(s)
Proteínas de Fusión gag-onc/fisiología , Agregación Plaquetaria , Proteínas Tirosina Quinasas/fisiología , Proteínas Proto-Oncogénicas/fisiología , Adenosina Difosfato/farmacología , Animales , Plaquetas/enzimología , Colágeno/farmacología , Proteínas de Fusión gag-onc/análisis , Humanos , Ratones , Ratones Transgénicos , Fosforilación/efectos de los fármacos , Agregación Plaquetaria/efectos de los fármacos , Glicoproteínas de Membrana Plaquetaria , Proteínas Tirosina Quinasas/análisis , Proteínas Proto-Oncogénicas/análisis , Receptores de Superficie Celular , Transducción de SeñalRESUMEN
The eukaryotic mRNA 3' poly(A) tail acts synergistically with the 5' cap structure to enhance translation. This effect is mediated by a bridging complex, composed of the poly(A) binding protein (PABP), eIF4G, and the cap binding protein, eIF4E. PABP-interacting protein 1 (Paip1) is another factor that interacts with PABP to coactivate translation. Here, we describe a novel human PABP-interacting protein (Paip2), which acts as a repressor of translation both in vitro and in vivo. Paip2 preferentially inhibits translation of a poly(A)-containing mRNA, but has no effect on the translation of hepatitis C virus mRNA, which is cap- and eIF4G-independent. Paip2 decreases the affinity of PABP for polyadenylate RNA, and disrupts the repeating structure of poly(A) ribonucleoprotein. Furthermore, Paip2 competes with Paip1 for PABP binding. Thus, Paip2 inhibits translation by interdicting PABP function.
Asunto(s)
Biosíntesis de Proteínas/fisiología , ARN Mensajero/metabolismo , Proteínas Represoras/genética , Proteínas Represoras/metabolismo , Animales , Unión Competitiva/genética , Western Blotting , Clonación Molecular , Codón Iniciador/genética , Hepacivirus/genética , Humanos , Técnicas In Vitro , Datos de Secuencia Molecular , Factores de Iniciación de Péptidos/genética , Factores de Iniciación de Péptidos/metabolismo , Pruebas de Precipitina , Proteínas de Unión al ARN , ConejosRESUMEN
The ubiquitous Fer protein-tyrosine kinase has been proposed to regulate diverse processes such as cell growth, cell adhesion, and neurite outgrowth. To gain insight into the biological function of Fer, we have targeted the fer locus with a kinase-inactivating missense mutation (fer(D743R)). Mice homozygous for this mutation develop normally, have no overt phenotypic differences from wild-type mice, and are fertile. Since these mice lack both Fer and the testis-specific FerT kinase activities, these proteins are clearly not essential for development and survival. No differences were observed in overall cellularity of bone marrow, spleen, or thymus in the absence of Fer activity. While most platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation was unchanged in fer(D743R) homozygous embryonic fibroblasts, cortactin phosphorylation was reduced. However, Fer kinase activity was not required for PDGF-induced Stat3, p120(ctn), or epidermal growth factor (EGF)-induced beta-catenin phosphorylation. Also, no defects were observed in changes to the actin cytoskeleton, adherens junctions, or focal adhesions in PDGF- or EGF-stimulated fer(D743R) homozygous embryonic fibroblasts. Therefore, Fer likely serves a redundant role in regulating cell growth, cell adhesion, retinal development, and spermatogenesis but is required for efficient phosphorylation of cortactin.
Asunto(s)
Fertilidad/genética , Eliminación de Gen , Proteínas de Microfilamentos/metabolismo , Proteínas Proto-Oncogénicas/deficiencia , Transactivadores , Actinas/metabolismo , Alelos , Animales , Cateninas , Moléculas de Adhesión Celular/metabolismo , Cortactina , Proteínas del Citoesqueleto/metabolismo , Citoesqueleto/química , Citoesqueleto/efectos de los fármacos , Citoesqueleto/metabolismo , Factor de Crecimiento Epidérmico/farmacología , Fibroblastos , Marcación de Gen , Genotipo , Inmunohistoquímica , Ratones , Ratones Noqueados , Fenotipo , Fosfoproteínas/metabolismo , Fosforilación/efectos de los fármacos , Factor de Crecimiento Derivado de Plaquetas/farmacología , Proteínas Tirosina Quinasas , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas/metabolismo , Transducción de Señal/efectos de los fármacos , Tasa de Supervivencia , beta Catenina , Catenina deltaRESUMEN
The protein-tyrosine kinase Fer and the highly homologous proto-oncoprotein Fps/Fes are implicated in signaling from a variety of growth factor and cytokine receptors. Here we examine the molecular basis of Fer kinase activation with an emphasis on the role of oligomerization. We show that Fer forms trimers in vivo and that disruption of either the first or second coiled-coil domain abolishes oligomerization, suggesting a cooperative interaction between these two domains. Although Fps/Fes also forms homotypic oligomers, probably via homologous coiled-coil domains, no heterotypic interactions were observed between Fer and Fps/Fes. Incorporation of catalytically inactive Fer peptides into the oligomeric complex caused only mild reduction of wild type Fer kinase activity, suggesting that kinase-inactive Fer would not behave as a potent dominant negative. Although oligomerization of Fer can potentiate autophosphorylation in trans at three major phosphorylation sites, these residues can likely also be phosphorylated in cis. In contrast, the testis-specific FerT isomer does not oligomerize and is able to autophosphorylate in cis at two of the same three residues autophosphorylated in Fer. These results suggest that although oligomerization potentiates autophosphorylation in trans, this is apparently not necessary for Fer activation.
Asunto(s)
Proteínas Tirosina Quinasas , Proteínas Proto-Oncogénicas/química , Animales , Células COS , Activación Enzimática , Proteínas de Fusión gag-onc/química , Proteínas Nucleares , Mapeo Peptídico , Fosfopéptidos/química , Fosforilación , Conformación Proteica , Estructura Secundaria de Proteína , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas/metabolismo , Transducción de Señal , Transfección , TripsinaRESUMEN
Before the structure of cAMP-dependent protein kinase had been solved, sequence alignments had already suggested that several highly conserved peptide motifs described as kinase subdomains I through XI might play some functional role in catalysis. Crystal structures of several members of the protein kinase superfamily have suggested that the nearly invariant aspartate residue within subdomain IX contributes to the conformational stability of the catalytic loop by forming hydrogen bonds with backbone amides within subdomain VI. However, substitution of this aspartate with alanine or threonine in some protein kinases have indicated that these interactions are not essential for activity. In contrast, we show here that conversion of this aspartate to arginine abolished the catalytic activity of the Fer protein-tyrosine kinase when expressed either in mammalian cells or in bacteria. Structural modeling predicted that the catalytic loop of the FerD743R mutant was disrupted by van der Waal's repulsion between the side chains of the substituted arginine residue in subdomain IX and histidine-683 in subdomain VI. The FerD743R mutant model predicted a shift in the peptide backbone of the catalytic loop, and an outward rotation of histidine-683 and arginine-684 side chains. However, the position and orientation of the presumptive catalytic base, aspartate-685, was not substantially changed. The proposed model explains how substitutions of some, but not all residues could be tolerated at this nearly invariant aspartate in kinase subdomain IX.
Asunto(s)
Ácido Aspártico/química , Proteínas Tirosina Quinasas/química , Proteínas Proto-Oncogénicas/química , Secuencia de Aminoácidos , Animales , Complejo Antígeno-Anticuerpo/metabolismo , Células COS , Simulación por Computador , Cartilla de ADN , Modelos Genéticos , Modelos Moleculares , Datos de Secuencia Molecular , Mutagénesis , Plásmidos , Proteínas Recombinantes de Fusión , Homología de Secuencia de Aminoácido , TransfecciónRESUMEN
In the initiation of translation in eukaryotes, binding of the small ribosomal subunit to the messenger RNA results from recognition of the 5' cap structure (m7GpppX) of the mRNA by the cap-binding complex eIF4F. eIF4F is itself a three-subunit complex comprising the cap-binding protein eIF4E, eIF4A, an ATP-dependent RNA helicase, and eIF4G, which interacts with both eIF4A and eIF4E and enhances cap binding by eIF4E. The mRNA 3' polyadenylate tail and the associated poly(A)-binding protein (PABP) also regulate translational initiation, probably by interacting with the 5' end of the mRNA. In yeast and plants, PABP interacts with eIF4G but no such interaction has been reported in mammalian cells. Here, we describe a new human PABP-interacting protein, PAIP-I, whose sequence is similar to the central portion of eIF4G and which interacts with eIF4A. Overexpression of PAIP-1 in COS-7 cells stimulates translation, perhaps by providing a physical link between the mRNA termini.
Asunto(s)
Factores de Iniciación de Péptidos/química , Factores de Iniciación de Péptidos/metabolismo , Biosíntesis de Proteínas , Proteínas de Unión al ARN/metabolismo , Secuencia de Aminoácidos , Animales , Sitios de Unión , Células COS , Clonación Molecular , Escherichia coli , Factor 4F Eucariótico de Iniciación , Factor 4G Eucariótico de Iniciación , Células HeLa , Humanos , Datos de Secuencia Molecular , Proteínas de Unión a Poli(A) , Pruebas de Precipitina , Unión Proteica , ARN Mensajero/metabolismo , Homología de Secuencia de Aminoácido , TransfecciónRESUMEN
The La autoantigen is an RNA-binding protein that is involved in initiation and termination of RNA polymerase III transcription. It also binds several viral RNAs, including those of poliovirus and human immunodeficiency virus (HIV). Binding of the La protein to these RNAs enhances their translation in vitro (K. Meerovitch, Y.V. Svitkin, H.S. Lee, F. Lejbkowicz, D.J. Kenan, E.K.L. Chan, V.L. Agol, J.D. Keene, and N. Sonenberg, J. Virol. 67:3798-3807, 1993, and Y.V. Svitkin, A. Pause, and N. Sonenberg, J. Virol. 68:7001-7007, 1994). Here, a functional domain in the carboxy-terminal half of La that is distinct from the RNA-binding domain is described. Deletion of this domain abrogated the ability of La protein to enhance translation of poliovirus RNA and a hybrid HIV trans-activation-response element-chloramphenicol acetyltransferase mRNA. Far-Western assays indicated that the La protein homodimerized in vitro, and the C-terminal deletions that caused a loss of activity in translation also abrogated the dimerization signal. Gel filtration chromatography of recombinant La protein confirmed that La protein exists as a dimer under native conditions. Addition of the purified dimerization domain resulted in a loss of translation stimulatory activity of La protein in cell-free-translation reactions.
Asunto(s)
Autoantígenos/química , Autoantígenos/farmacología , Biosíntesis de Proteínas/efectos de los fármacos , Ribonucleoproteínas/química , Ribonucleoproteínas/farmacología , Autoantígenos/genética , Autoantígenos/aislamiento & purificación , Cloranfenicol O-Acetiltransferasa/genética , Dimerización , VIH-1/genética , Humanos , Peso Molecular , Poliovirus/genética , ARN/metabolismo , ARN Mensajero/metabolismo , ARN Viral/metabolismo , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/aislamiento & purificación , Ribonucleoproteínas/genética , Ribonucleoproteínas/aislamiento & purificación , Eliminación de Secuencia , Antígeno SS-BRESUMEN
Interferon-induced protein kinase (PKR) is a member of a family of kinases that regulate translation initiation through phosphorylation of eukaryotic initiation factor 2alpha. In addition to the conserved catalytic subdomains that are present in all serine/threonine kinases, the eukaryotic initiation factor 2alpha kinases possess an insert region between catalytic subdomains IV and V that has been termed the kinase insert domain. To investigate the importance of the kinase insert domain of PKR, several deletions and point mutations were introduced within this domain and analyzed for kinase activity both in vitro and in vivo. Here we show that deletion of the kinase insert sequence or mutation of serine 355, which lies within this region, abrogates kinase activity. In addition, the kinase insert domain of PKR and adjacent amino acids (LFIQME) in catalytic subdomain V are not required for binding of the pseudosubstrate inhibitor K3L from vaccinia virus. A portion of the catalytic domain of PKR between amino acids 366 and 415 confers K3L binding in vivo, suggesting a possible role for this region of PKR in substrate interaction.
Asunto(s)
Interferones/farmacología , Proteínas Serina-Treonina Quinasas/biosíntesis , Secuencia de Aminoácidos , Animales , Células COS , Catálisis , Inducción Enzimática , Células HeLa , Humanos , Datos de Secuencia Molecular , Mutagénesis , Proteínas Serina-Treonina Quinasas/genética , Proteínas Serina-Treonina Quinasas/metabolismo , Alineación de Secuencia , Especificidad por Sustrato , eIF-2 QuinasaRESUMEN
PKR is an interferon (IFN)-induced serine/threonine protein kinase that regulates protein synthesis through phosphorylation of eukaryotic translation initiation factor-2 (eIF-2). In addition to its demonstrated role in translational control, recent findings suggest that PKR plays an important role in regulation of gene transcription, as PKR phosphorylates I kappa B alpha upon double-stranded RNA treatment resulting in activation of NF-kappa B DNA binding in vitro (Kumar, A., Haque, J., Lacoste, J., Hiscott, J., and Williams, B.R.G. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 6288-6292). To further investigate the role of PKR in transcriptional signaling, we expressed the wild type human PKR and a catalytically inactive dominant negative PKR mutant in the murine pre-B lymphoma 70Z/3 cells. Here, we report that expression of wild type PKR had no effect on kappa-chain transcriptional activation induced by lipopolysaccharide or IFN-gamma. However, expression of the dominant negative PKR mutant inhibited kappa gene transcription independently of NF-kappa B activation. Phosphorylation of eIF-2 alpha was not increased by lipopolysaccharide or IFN-gamma, suggesting that PKR mediates kappa gene transcriptional activation without affecting protein synthesis. Our findings further support a transcriptional role for PKR and demonstrate that there are at least two distinct PKR-mediated signal transduction pathways to the transcriptional machinery depending on cell type and stimuli, NF-kappa B-dependent and NF-kappa B-independent.
Asunto(s)
Regulación Neoplásica de la Expresión Génica , Genes de Inmunoglobulinas , Cadenas kappa de Inmunoglobulina/genética , Proteínas Serina-Treonina Quinasas/metabolismo , Transducción de Señal , Animales , Secuencia de Bases , Inducción Enzimática , Factor 2 Eucariótico de Iniciación/metabolismo , Regulación del Desarrollo de la Expresión Génica , Humanos , Inmunoglobulina M/biosíntesis , Linfoma de Células B , Ratones , Datos de Secuencia Molecular , Mutación , FN-kappa B/metabolismo , Fosforilación , Lesiones Precancerosas , Proteínas Serina-Treonina Quinasas/genética , ARN Neoplásico/biosíntesis , Receptores de Antígenos de Linfocitos B/biosíntesis , Proteínas Recombinantes/metabolismo , Eliminación de Secuencia , Transcripción Genética , Células Tumorales Cultivadas , eIF-2 QuinasaRESUMEN
Pretreatment of rats by the repeated administration of certain alkylating carcinogens has been shown to stimulate the removal of O6-alkylguanine from hepatic DNA. Prolonged feeding with the aromatic amide 2-acetylaminofluorene has a similar effect. In this report, aflatoxin B1, an agent from another chemically distinct class of carcinogen, is shown to be capable of stimulating the repair of O6-methylguanine in hepatic DNA. The sensitivity of this system is shown by the fact that this repair response can be fully stimulated as early as 1 day after treatment with a single dose.
Asunto(s)
Aflatoxinas/farmacología , Reparación del ADN/efectos de los fármacos , Guanina/análogos & derivados , Hígado/metabolismo , Adenina/análogos & derivados , Adenina/biosíntesis , Aflatoxina B1 , Animales , Dimetilnitrosamina/farmacología , Guanina/biosíntesis , Masculino , Ratas , Estimulación QuímicaRESUMEN
Methylated purines were determined in the liver and kidney DNA of rats that had been pretreated for several weeks by inclusion of 2-acetylaminofluorene in the diet and then given single injections of N,N-dimethylnitrosamine. In comparison ith relevant controls the capacity to remove O(6)-methylguanine from the livers of the pretreated animals was enhanced but there was no evidence for a similar effect in kidney. No market effects of this pretreatment were observed for the removal of 3-methyladenine or 7-methylguanine. The data indicate that an inducing agent may affect the capacity of an animal to repair DNA which is subsequently damaged by another agent of chemically different identity. The mechanisms involved are not clear but potentially these observations have wide implications when organisms are exposed to a variety of chemicals.
Asunto(s)
2-Acetilaminofluoreno/farmacología , ADN/metabolismo , Dimetilnitrosamina/farmacología , Hígado/metabolismo , Purinas/metabolismo , Animales , ADN Polimerasa Dirigida por ADN/metabolismo , Dieta , Dimetilnitrosamina/metabolismo , Crecimiento/efectos de los fármacos , Hígado/efectos de los fármacos , Masculino , Ratas , Ratas Endogámicas , Timidina/metabolismoRESUMEN
The removal of the promutagenic DNA alkylation product O6-methylguanine from different fractions of rat liver DNA has been examined using the technique of DNA-DNA reassociation. Male Wistar rats were given a low non-toxic dose of N,N-dimethylnitrosamine (DMN) (2 mg/kg) and killed 3 or 18 h later (a period corresponding to the removal of 50% of the O6-methylguanine from 'total' liver (DNA). DNA was extracted from liver, denatured in alkali and incubated at 60 degrees C for periods corresponding to the reassociation of highly repetitive (polycopy), middle repetitive and 'unique' sequences i.e. different 'kinetic' classes of DNA. Reassociated and single-stranded DNA were separated by hydroxyapatite chromatography and analyse for O6-methylguanine content. Three hours after administration of DMN the levels of O6-methylguanine in the reassociated and single-stranded DNA were the same after each period of reassociation indicating that O6-methylguanine was randomly distributed among the DNA classes. At 18 h the levels of O6-methylguanine were again the same in the reassociated and single-stranded DNA but approx. 50% lower than in the 3 h DNA samples. The rate of loss of O6-methylguanine from the three DNA classes was thus the same and there was therefore no indication of preferential removal of this base from any one kinetic class of DNA under the conditions used.
Asunto(s)
Reparación del ADN , Dimetilnitrosamina/farmacología , Guanina/análogos & derivados , Hígado/metabolismo , Animales , Cromatina/metabolismo , ADN de Cadena Simple/metabolismo , Guanina/metabolismo , Masculino , Metilación , Desnaturalización de Ácido Nucleico , RatasRESUMEN
The acute toxicity and carcinogenicity of dimethylnitrosamine (DMN) have been examined in the Chinese hamster (Cricetulus griseus). A single dose of 20 mg/kg or less was not acutely lethal but at 30 mg/kg only a few animals survived. Liver tumours were found in all of the animals surviving two doses of 20 mg/kg and so far, 25 months after treatment, in 80% of the animals given a single dose of 20 mg/kg. Altering the diet to sucrose lumps and 20% glucose in the drinking water ad libitum for 3 days prior to DMN treatment had only a slight effect on acute toxicity and carcinogenicity. In biochemical studies, DNA was extracted from several tissues of animals killed 9 h after DMN administration (20 mg/kg). The amounts of normal and methylated purines were determined after mild acid hydrolysis and Sephadex G-10 chromatography. The highest level of methylated bases was found in the DNA of the liver. Measurement of the persistence of methylated guanines showed that liver, kidney, and lung were able to remove the major product 7-methylguanine from DNA while none of these tissues had any capacity to remove the pro-mutagenic lesion O6-methylguanine. These results are discussed in relation to the mechanism of action and tissue specificity of alkylating carcinogens in this and other experimental animal systems.